Seres Therapeutics, Inc. — All Filings
682 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
144
3
3/A
4
4/A
424B3
424B4
424B5
8-A12B
8-K
CERTNAS
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DEFM14A
DRS
DRS/A
EFFECT
FWP
POS AM
POSASR
PRE 14A
PREM14A
S-1
S-1/A
S-1MEF
S-3
S-3ASR
S-8
S-8 POS
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 4 | 4 | 0000950170-25-053247 | Apr 11, 2025 | Apr 10, 2025 |
| 4 | 4 | 0000950170-25-053249 | Apr 11, 2025 | Apr 10, 2025 |
| 4 | 4 | 0000950170-25-053248 | Apr 11, 2025 | Apr 10, 2025 |
| 4 | 4 | 0000950170-25-053243 | Apr 11, 2025 | Apr 10, 2025 |
| DEFA14A | DEFA14A | 0001193125-25-072547 | Apr 4, 2025 | — |
| 10-K | 10-K | 0000950170-25-038427 | Mar 13, 2025 | Dec 31, 2024 |
| S-8 | S-8 | 0001193125-25-053676 | Mar 13, 2025 | — |
| DEF 14A | DEF 14A | 0000950170-25-038441 | Mar 13, 2025 | — |
| 8-K | 8-K | 0001193125-25-053473 | Mar 13, 2025 | — |
| PRE 14A | PRE 14A | 0000950170-25-030842 | Mar 3, 2025 | — |
| 8-K | 8-K | 0001193125-25-039256 | Feb 27, 2025 | Feb 22, 2025 |
| 4 | 4 | 0000950170-25-023580 | Feb 19, 2025 | Feb 15, 2025 |
| 4 | 4 | 0000950170-25-023575 | Feb 19, 2025 | Feb 15, 2025 |
| 4 | 4 | 0000950170-25-023584 | Feb 19, 2025 | Feb 15, 2025 |
| 4 | 4 | 0000950170-25-023573 | Feb 19, 2025 | Feb 15, 2025 |
| 4 | 4 | 0000950170-25-023569 | Feb 19, 2025 | Feb 15, 2025 |
| SCHEDULE 13G/A | — | 0000315066-25-000814 | Feb 12, 2025 | — |
| 4 | 4 | 0000950170-25-017916 | Feb 11, 2025 | Feb 7, 2025 |
| 4 | 4 | 0000950170-25-017913 | Feb 11, 2025 | Feb 7, 2025 |
| 4 | 4 | 0000950170-25-017910 | Feb 11, 2025 | Feb 7, 2025 |
| 4 | 4 | 0000950170-25-017911 | Feb 11, 2025 | Feb 7, 2025 |
| 4 | 4 | 0000950170-25-017914 | Feb 11, 2025 | Feb 7, 2025 |
| 4 | 4 | 0000950170-25-017912 | Feb 11, 2025 | Feb 7, 2025 |
| 3 | 3 | 0000950170-25-015016 | Feb 6, 2025 | Feb 4, 2025 |
| 8-K | 8-K | 0001193125-25-021345 | Feb 6, 2025 | Feb 4, 2025 |
| 4 | 4 | 0000950170-25-015020 | Feb 6, 2025 | Feb 4, 2025 |
| 8-K | 8-K | 0001193125-25-005011 | Jan 13, 2025 | — |
| 8-K | 8-K | 0001193125-25-004062 | Jan 10, 2025 | Jan 9, 2025 |
| 4 | 4 | 0000950170-24-128613 | Nov 19, 2024 | Nov 15, 2024 |
| 4 | 4 | 0000950170-24-128626 | Nov 19, 2024 | Nov 15, 2024 |
| 4 | 4 | 0000950170-24-128609 | Nov 19, 2024 | Nov 15, 2024 |
| 4 | 4 | 0000950170-24-128631 | Nov 19, 2024 | Nov 15, 2024 |
| 4 | 4 | 0000950170-24-128611 | Nov 19, 2024 | Nov 15, 2024 |
| 10-Q | 10-Q | 0000950170-24-126018 | Nov 13, 2024 | Sep 30, 2024 |
| 8-K | 8-K | 0001193125-24-256654 | Nov 13, 2024 | Nov 7, 2024 |
| 4 | 4 | 0000950170-24-118424 | Oct 29, 2024 | Oct 27, 2024 |
| 4 | 4 | 0000950170-24-118415 | Oct 29, 2024 | Oct 27, 2024 |
| 4 | 4 | 0000950170-24-118418 | Oct 29, 2024 | Oct 27, 2024 |
| 4 | 4 | 0000950170-24-118405 | Oct 29, 2024 | Oct 27, 2024 |
| 4 | 4 | 0000950170-24-118409 | Oct 29, 2024 | Oct 27, 2024 |
| 424B3 | 424B3 | 0001193125-24-236757 | Oct 11, 2024 | — |
| EFFECT | — | 9999999995-24-003174 | Oct 11, 2024 | — |
| CORRESP | — | 0001193125-24-235165 | Oct 9, 2024 | — |
| UPLOAD | — | 0000000000-24-011398 | Oct 8, 2024 | — |
| SC 13D/A | SC 13D/A | 0001193125-24-230718 | Oct 2, 2024 | — |
| 3 | 3 | 0000950170-24-111110 | Oct 2, 2024 | Sep 30, 2024 |
| 8-K | 8-K | 0001193125-24-230144 | Oct 1, 2024 | Sep 30, 2024 |
| S-3 | S-3 | 0001193125-24-230253 | Oct 1, 2024 | — |
| 8-K | 8-K | 0001193125-24-226929 | Sep 26, 2024 | — |
| DEFA14A | DEFA14A | 0001193125-24-217668 | Sep 12, 2024 | — |